Jeff Johnson
Stock Analyst at Baird
(2.83)
# 563
Out of 5,240 analysts
152
Total ratings
58.24%
Success rate
35.72%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Patterson Cos | Maintains: Neutral | 25 31 | 30.88 | 0.39% | 7 | Dec 12, 2024 | |
Tandem Diabetes Care | Maintains: Neutral | 39 37 | 36.65 | 0.95% | 14 | Nov 7, 2024 | |
Envista Holdings | Maintains: Neutral | 17 22 | 19.08 | 15.3% | 7 | Oct 31, 2024 | |
Stryker | Maintains: Outperform | 378 405 | 367.45 | 10.22% | 11 | Oct 30, 2024 | |
Align Tech | Maintains: Outperform | 325 276 | 217.44 | 26.93% | 16 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 118 125 | 90.84 | 37.6% | 15 | Aug 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 104 110 | 82.84 | 32.79% | 8 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 155 145 | 104.73 | 38.45% | 13 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 92 82 | 71.91 | 14.03% | 9 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 80 82 | 81.78 | 0.27% | 12 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 180 238 | 269.13 | -11.57% | 12 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 67 70 | 45.55 | 53.68% | 2 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 53 61 | 16.54 | 268.8% | 4 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 78 67 | 18.59 | 260.41% | 6 | Feb 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 56 | n/a | n/a | 7 | Oct 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 178 | n/a | n/a | 6 | Oct 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 28 31 | n/a | n/a | 3 | Nov 11, 2019 |